Evidence map›Paper›PMID 33598441›Full record

ArticleFrontiers in pediatrics2021

The Edge of Perinatal Viability: Understanding the Dutch Position.

L De Proost, E J T Verweij, H Ismaili M'hamdi, I K M Reiss, E A P Steegers, R Geurtzen, A A E Verhagen

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.Archives of disease in childhood. Fetal and neonatal edition · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

L De ProostDepartment of Medical Ethics, Philosophy and History of Medicine, Rotterdam, Netherlands.
E J T VerweijDepartment of Obstetrics and Gynecology, Rotterdam, Netherlands.
H Ismaili M'hamdiDepartment of Medical Ethics, Philosophy and History of Medicine, Rotterdam, Netherlands.
I K M ReissDepartment of Neonatology, Rotterdam, Netherlands.
E A P SteegersDepartment of Obstetrics and Gynecology, Rotterdam, Netherlands.
R GeurtzenDepartment of Neonatology, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen, Netherlands.
A A E VerhagenDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current Dutch guideline on care at the edge of perinatal viability advises to consider initiation of active care to infants born from 24 weeks of gestational age on. This, only after extensive counseling of and shared decision-making with the parents of the yet unborn infant. Compared to most other European guidelines on this matter, the Dutch guideline may be thought to stand out for its relatively high age threshold of initiating active care, its gray zone spanning weeks 24 and 25 in which active management is determined by parental discretion, and a slight reluctance to provide active care in case of extreme prematurity. In this article, we explore the Dutch position more thoroughly. First, we briefly look at the previous and current Dutch guidelines. Second, we position them within the Dutch socio-cultural context. We focus on the Dutch prioritization of individual freedom, the abortion law and the perinatal threshold of viability, and a culturally embedded aversion of suffering. Lastly, we explore two possible adaptations of the Dutch guideline; i.e., to only lower the age threshold to consider the initiation of active care, or to change the type of guideline.

Indexed as

decision-makingextremely premature birthguidelinesmedical ethicsthreshold of viability

Identifiers

PMID33598441
PMCPMC7882530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.